The development of phage display technology has facilitated the development
of many new and sometimes novel antibody based reagents for scientific res
earch. However, present methods for selection from phase-sFv display librar
ies are limited to selection against purified antigens or ex vivo cells of
known origin and phenotype. Existing methods therefore preclude the isolati
on of sFv against unknown molecules in their natural environment, where exp
ression is complex and subject to diverse control mechanisms. Since such a
complex environment is difficult to mimic in vitro, the development of an i
n vivo selection procedure would greatly enhance the selection from phage d
isplay antibody libraries and lead to the development of reagents against c
ell surface molecules in their natural environment. This would be particula
rly advantageous for isolation of sFv against vascular endothelium which ca
n readily change phenotype when cultured and is believed to express molecul
es in a tissue specific manner and in response to different stimuli. We des
cribe here the development of an in vivo selection procedure in the mouse a
nd demonstrate its potential for the selection of sFv from a phase-sFv libr
ary. The target antigen for one sFv is expressed solely on the thymic endot
helium, while the second, a 165-170 kDa molecule in present on both thymic
endothelium and the perivascular epithelium. (C) 2000 Elsevier Science B.V.
All rights reserved.